Veterinary Drugs Business Investment Opportunity in Chennai, India
Seller and marketer of animal pharma products in 4 territories with 2 distributors each.
This transaction has concluded.
Premium Plan
| Established | 5-10 year(s) |
| Employees | 2 - 5 |
| Legal Entity | Sole Proprietorship/Sole Trader |
| Reported Sales | USD 46 thousand |
| Run Rate Sales | USD 28.4 thousand |
| EBITDA Margin | Operating at loss |
| Industries | Veterinary Drugs |
| Locations | Chennai |
| Local Time | 4:49 PM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
59 thousand
for
10.0%
stake
(Native Currency: INR 5,000,000)
Reason: Expansion of territories in order to bring down our per unit cost of sales.
Includes physical assets worth
USD
59 thousand
Business Overview
- We are an animal pharmaceuticals marketing and sales company.
- Currently we are operating in 4 territories which are Tamil Nadu, Karnataka, Andhra Pradesh and Telangana.
- Each territory has around 2 distributors with 100+ clients including veterinarians and para-veterinarians.
- We sell around 16 registered brands and we have 7 brands currently in the pipeline.
- The firm has a registered drug licence to hold and sell these drugs.
- Promoter has been working in this field since 2009 and also has hired a full time consultant who has worked at one of the top 5 veterinary pharma companies.
- The firm does not own any physical assets except for stock and inventory.
- At present the per unit cost of sales are high since the firm is only operating in a few territories and thats why sales have reduced. We are expanding to more territories which will lower this cost and enable the firm to generate profits and improve sales.
- Currently we are operating in 4 territories which are Tamil Nadu, Karnataka, Andhra Pradesh and Telangana.
- Each territory has around 2 distributors with 100+ clients including veterinarians and para-veterinarians.
- We sell around 16 registered brands and we have 7 brands currently in the pipeline.
- The firm has a registered drug licence to hold and sell these drugs.
- Promoter has been working in this field since 2009 and also has hired a full time consultant who has worked at one of the top 5 veterinary pharma companies.
- The firm does not own any physical assets except for stock and inventory.
- At present the per unit cost of sales are high since the firm is only operating in a few territories and thats why sales have reduced. We are expanding to more territories which will lower this cost and enable the firm to generate profits and improve sales.
Products & Services Overview
5 segments of medicine with 16 brands registered and 7 in the pipeline. Includes pharmaceuticals for Mastitis, Infertility, Hameo Protozoan infections, infectious diseases and immune system problems.
Facilities Overview
No office but have a rented area of 500 Sq Ft to store the inventory.
Capitalization Overview
Not Disclosed
Recent Activity
-
Earlier than 15 daysManaging Partner, Biotechnology, Chennai, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysDirector, Technology & Leasing, Mumbai, Corporate Investor / Buyer connected with the Business
Tags:
Veterinary Drugs Business Investment Opportunity in Chennai, India
·Veterinary Drugs Business Investment Opportunity in Madras
·Invest in Veterinary Drugs Business in Chennai, India
·Veterinary Drugs Business Investment Opportunity
·Invest in Veterinary Drugs Business in Madras
·Investment Opportunity in Chennai, India
·Invest in Veterinary Drugs Business
·Investment Opportunity in Madras
·Invest in Chennai, India
·Invest in Madras
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
